Lumason .19 mg/mg

Lumason .19 mg/mg is a diagnostic imaging agent used to enhance ultrasound images. This lyophilized powder for suspension is administered intravenously or intravesically for improved visualization.

Lumason .19 mg/mg is primarily used as a contrast agent in ultrasound imaging. It helps to enhance the visibility of blood flow and tissue structures, aiding in the diagnosis of various conditions. This agent is often utilized in procedures where detailed imaging is required, such as evaluating heart function or detecting abnormalities in blood vessels.

When administered, Lumason .19 mg/mg typically enhances the clarity of ultrasound images, allowing healthcare professionals to better assess internal structures. The effects are temporary and designed to provide clear, detailed images during the diagnostic procedure.

Lumason .19 mg/mg should be handled with care, following standard protocols for intravenous and intravesical administration. It is important to ensure that the product is stored and prepared correctly to maintain its efficacy and safety. Always follow the guidelines provided by healthcare professionals.

Lumason .19 mg/mg may interact with certain medications or conditions. It is advisable to inform healthcare providers about any existing medical conditions or medications being taken before administration. Specific interactions should be discussed with a healthcare professional.